ASSIGNMENT AND ASSUMPTION OF EMPLOYMENT AGREEMENTAssignment and Assumption of Employment Agreement • March 31st, 2021 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • New York
This Assignment and Assumption (this “Agreement”) of Employment Agreement is made as of March 30, 2021 (the “Effective Date”), by and among Brooklyn ImmunoTherapeutics LLC, a Delaware limited liability company (“Assignor”), Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (“Assignee”), and Lynn Sadowski Mason (“Mason” and, collectively with Assignor and Assignee, the “Parties”).
ASSIGNMENT AND ASSUMPTION OF EMPLOYMENT AGREEMENTAssignment and Assumption of Employment Agreement • March 31st, 2021 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • New York
This Assignment and Assumption (this “Agreement”) of Employment Agreement is made as of March 30, 2021 (the “Effective Date”), by and among Brooklyn ImmunoTherapeutics LLC, a Delaware limited liability company (“Assignor”), Brooklyn ImmunoTherapeutics, Inc., a Delaware corporation (“Assignee”), and Ronald Guido (“Guido” and, collectively with Assignor and Assignee, the “Parties”).
AMENDED AND RESTATED ROYALTY AGREEMENT AND DISTRIBUTION AGREEMENTRoyalty Agreement and Distribution Agreement • March 31st, 2021 • Brooklyn ImmunoTherapeutics, Inc. • Pharmaceutical preparations • New York
This Amended and Restated Royalty Agreement and Distribution Agreement (this “Agreement”) is entered into as of March 22, 2021 by and between Brooklyn Immunotherapeutics, LLC, a Delaware limited liability company with offices located at Brooklyn Army Terminal, 140 58th Street, Bldg. A, Suite 2100, Brooklyn, NY 11220 (the “Company”), Brooklyn Immunotherapeutics Investors GP LLC, a Delaware limited liability company (“Investors GP”), Brooklyn Immunotherapeutics Investors LP, a Delaware limited partnership (“Investors LP”), and the beneficiary parties listed on Schedule A (“the “Holders”). Each of the Company, Investors GP, Investors LP and the Holders are jointly referred to herein as the “Parties” and each, individually, as a “Party.”
